MedSurg Will Likely Drive Boston Scientific's Near-Term Earnings Growth

Boston Scientific (NYSE:BSX) has seen steady top line growth in the recent quarters, led by robust demand for its products across all segments. The MedSurg segment in particular has seen high growth of late, led by higher demand for Endoscopy and Urology and Pelvic Health products. We expect this...